Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Glaxo Wellcome studies lamotrigine analogues in the search for new anticonvulsants

Sep. 17, 1998

Astra Arcus develops first full, selective alpha7 nAChR agonist

Sep. 17, 1998

Selective 5-HT2C antagonist selected for development at Organon

Sep. 17, 1998

European marketing application for Myotrophin withdrawn

Sep. 16, 1998

Algos releases phase III clinical trial results for MorphiDex

Sep. 16, 1998

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Sep. 16, 1998

S-23751: new 5-HT1A/5-HT7 receptor ligand with anxiolytic activity

Sep. 16, 1998

Potent and selective 5-HT1B/1D antagonists designed by Merck KGaA

Sep. 16, 1998

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Sep. 16, 1998

Wafer formulation of rizatriptan delivers fast and effective migraine relief

Sep. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...